Human IL-33 Antibody

Mouse IgG1 (clone 19G8) - Hybridoma 

Human IL-33 Antibody

ABOUT

Neutralizing monoclonal antibody against human interleukin 33

Anti-hIL-33-IgG (clone 19G8) is a monoclonal antibody (mAb) specific for human interleukin 33 (hIL-33). It is produced in hybridomas and purified by affinity chromatography. This antibody has been selected for its ability to efficiently neutralize the biological activity of hIL-33. IL-33 is a pro-inflammatory cytokine that shares structural and functional characteristics with the IL-1 cytokine family. It binds and signals through the IL-1RL1/ IL-1R accessory protein (IL-1RAcP) receptor activating NF-κB and MAP kinases.

More details More details

 

Key features:

  • A potent and specific neutralizing mAb against hIL-33
  • Provided azide-free
  • Each lot is functionally tested

 

References:

1. Arend W. et al., 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 223:20-38.
2. Schiering C. et al., 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. 513(7519):564-8.

All products are for research use only, and not for human or veterinary use.

SPECIFICATIONS

Specifications

Target

Il-33

Target species

Human

Species
Human
Isotype
mIgG1
kappa
Clone
19G8
Tag
Tag-free
Source
Hybridoma
Purification
Protein G
Formulation buffer

Sodium phosphate buffer, glycine, saccharose, stabilizing agents

Preservative
Azide-free
Reconstitution buffer
Sterile water (not provided)
Tested applications

Neutralization assay

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    Anti-hIL-33-IgG
  • Cat code: 
    mabg-hil33-3
  • Quantity: 
    3 x 100 µg

Shipping & Storage

  • Shipping method:  Room temperature
  • Storage:

    • -20 °C
    Stability: -20°C for up to 1 year

    Caution:

    • Avoid repeated freeze-thaw cycles

Details

Interleukin-33 (IL-33; also known as IL-1F11) is a member of the IL-1 family, a group of cytokines that play important roles in host defense, immune regulation, and inflammation [1]. IL-33 mediates its biological effects through  IL1RL1  (also known as ST2), a receptor expressed on Th2 and mast cells. IL-33 and  IL1RL1 form a complex with IL-1R accessory protein (IL-1RAcP), a signaling receptor subunit that is also a member of the IL-1R complex. IL-33 signaling leads to the activation of NF-κB and MAP kinases.

IL-33 can function both as a traditional cytokine and as a nuclear factor regulating gene transcription. Following pro-inflammatory stimulation, Il-33 can induce Th2-biased immune responses, such as the production of IL-4, IL-5 and IL-13 [2]. In addition, as IL-33 is constitutively expressed in endothelial and epithelial cells, it can act as an endogenous danger signal, or damage-associated molecular pattern (DAMP; also called alarmins), in response to tissue damage [3, 4].

 

1. Arend W. et al., 2008. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 223:20-38.
2. Schiering C. et al., 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. 513(7519):564-8.
3. Cayrol C. & Girard JP., 2014. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 31-7.
4. Oboki K. et al., 2011. IL-33 and airway inflammation. Allergy Asthma Immunol Res. 3(2): 81–88 

DOCUMENTS

Documents

Anti-hIL-33-IgG

Technical Data Sheet

Safety Data Sheet

Validation Data Sheet

Certificate of analysis

Need a CoA ?

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?